Skip to main content
Clinical Trials/NCT04892030
NCT04892030CompletedNot Applicable

A Pilot Study of a Novel Ad Libitum Plant-Based Behavioral Weight Loss Treatment

Drexel University2 sites in 1 country22 target enrollmentStarted: November 25, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
2
Primary Endpoint
Retention feasibility as assessed by the number of participants successfully retained in the intervention

Study Overview

Brief Summary

Many individuals do not achieve clinically significant weight loss following traditional lifestyle modification interventions, potentially because weight loss is dependent upon calorie tracking compliance (to achieve calorie prescriptions), which decreases over time for most. By contrast, non-energy-restricted whole food plant-based diets (WFPBD) have been demonstrated to promote clinically significant weight loss even without calorie prescriptions. The present pilot trial represents the first, to the knowledge of our study team, to empirically test a remotely delivered WFPBD behavioral weight loss intervention for adults with overweight or obesity. Over 12-weeks, participants (N = 21) will follow a non-energy-restricted WFPBD and received nutritional counseling and behavioral weight loss intervention. Participation will occur in two phases (Phase 1: n = 7; Phase 2: n = 14), between which iterative changes to the intervention will be made. Assessments will occur at baseline, mid-treatment, post-treatment, and 3-month follow-up. Data will be analyzed using an intent-to-treat approach. The primary aims of the study will be to assess retention feasibility and acceptability. The secondary aims will be to evaluate the preliminary effectiveness of the intervention on: (1) percent weight loss; (2) dietary intake (i.e., increased intake of low-fat plant-based whole foods and decreased in intake of processed foods and animal products); and (3) waist circumference. The exploratory aims will be to evaluate the preliminary effectiveness of the intervention on physical- and mental health-related quality of life, and to examine potential moderators of treatment success (plant-based diet history, internal disinhibition, social support vs. social sabotage, self-compassion, and psychological flexibility).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Aged 18-75
  • Current BMI ≥ 25 kg/m2
  • Reporting a desire to lose weight
  • Have at-home internet access
  • Proficiency in speaking, reading, and writing English
  • Willing to consume a whole foods plant-based diet for the study duration

Exclusion Criteria

  • Use of medications for weight loss
  • Recent weight loss (≥5% weight loss in prior 3-months)
  • Current or planned pregnancy within the study period
  • History of bariatric surgery
  • Currently following a low-fat plant-based diet
  • Diagnosis of a serious medical condition influencing weight, appetite, or eating behavior
  • Diagnosis of a serious psychiatric condition that may influence weight, appetite, or eating behavior
  • Current substance use disorder
  • Participation in a concurrent weight loss program
  • Planning on quitting smoking over the intervention period (if current smoker)
  • Eating pathology (lifetime history of an eating disorder, ≥ 9 binge eating episodes in the past 3 months, or > 5 compensatory episodes in the past 3 months)

Outcomes

Primary Outcomes

Retention feasibility as assessed by the number of participants successfully retained in the intervention

Time Frame: Week 12 (post-intervention)

The number of participants who are retained in the study, as defined by completing the post-treatment assessment and at least 10 out of 12 of the weekly intervention modules. Successful retention will be defined as at least 80% of participants being retained in the study.

Acceptability as assessed by self-reported acceptability of the intervention

Time Frame: Week 12 (post-intervention)

Acceptability will be assessed with three items, in which participants will report the degree to which they were satisfied with the intervention, found the intervention to be helpful, and the likelihood that they would recommend it to family/friends on a Likert scale ranging from 1 (Not at all) to 5 (Very much).

Secondary Outcomes

  • Preliminary effectiveness of the intervention on weight loss, as assessed by self-reported weight from baseline to post-intervention(Measured once weekly from Week 0 (baseline) to Week 12 (post-intervention), and at 3-month follow-up)
  • Preliminary effectiveness of the intervention on waist circumference, as assessed by self-reported waist circumference from baseline to post-intervention(Week 0 (baseline), Week 6 (mid-treatment), Week 12 (post-intervention), and 3-month follow-up)
  • Preliminary effectiveness of the intervention on dietary intake, as assessed by self-reported dietary intake from baseline to post-intervention(Week 0 (baseline), Week 6 (mid-treatment), Week 12 (post-intervention), and 3-month follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Evan Forman

Professor of Psychology, Drexel University

Drexel University

Study Sites (2)

Loading locations...

Similar Trials